![[Article Title]](https://media.americanpharmaceuticalreview.com/m/28/article/628973-134x100.jpg)
Paper records can slow down environmental monitoring and make errors more likely, especially at large scale. This white paper shows how Samsung Biologics moved its sampling process from paper to a fully digital system that records data automatically and keeps everything in one secure place. Read how the switch made sampling easier for operators, improved compliance and traceability, and cut down on errors and costs. You’ll also see how the team managed the transition, and how going paperless helps prepare manufacturers for a more connected, data-driven future.